EP1080185A4 - Peptides de proteine basique de myeline et utilisations de ceux-ci - Google Patents

Peptides de proteine basique de myeline et utilisations de ceux-ci

Info

Publication number
EP1080185A4
EP1080185A4 EP99920379A EP99920379A EP1080185A4 EP 1080185 A4 EP1080185 A4 EP 1080185A4 EP 99920379 A EP99920379 A EP 99920379A EP 99920379 A EP99920379 A EP 99920379A EP 1080185 A4 EP1080185 A4 EP 1080185A4
Authority
EP
European Patent Office
Prior art keywords
basic protein
myelin basic
protein peptides
peptides
myelin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99920379A
Other languages
German (de)
English (en)
Other versions
EP1080185A2 (fr
Inventor
Subhashini Arimilli
Shrikant Deshpande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of EP1080185A2 publication Critical patent/EP1080185A2/fr
Publication of EP1080185A4 publication Critical patent/EP1080185A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP99920379A 1998-05-05 1999-05-05 Peptides de proteine basique de myeline et utilisations de ceux-ci Withdrawn EP1080185A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7310998A 1998-05-05 1998-05-05
US73109 1998-05-05
PCT/US1999/009930 WO1999057241A2 (fr) 1998-05-05 1999-05-05 Peptides de proteine basique de myeline et utilisations de ceux-ci

Publications (2)

Publication Number Publication Date
EP1080185A2 EP1080185A2 (fr) 2001-03-07
EP1080185A4 true EP1080185A4 (fr) 2005-01-26

Family

ID=22111789

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99920379A Withdrawn EP1080185A4 (fr) 1998-05-05 1999-05-05 Peptides de proteine basique de myeline et utilisations de ceux-ci

Country Status (10)

Country Link
EP (1) EP1080185A4 (fr)
JP (1) JP2002513558A (fr)
CN (1) CN1308671A (fr)
AU (1) AU3789099A (fr)
CA (1) CA2330826A1 (fr)
HK (1) HK1039636A1 (fr)
NO (1) NO20005547L (fr)
NZ (1) NZ507901A (fr)
WO (1) WO1999057241A2 (fr)
ZA (1) ZA200006268B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002254753C1 (en) * 2001-05-01 2008-09-18 The Regents Of The University Of California Fusion molecules and methods for treatment of immune diseases
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
DK2227486T3 (da) * 2007-11-20 2017-06-19 Vianex S A Peptidanaloger og konjugater dermed
KR20200020966A (ko) * 2015-03-30 2020-02-26 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 면역용 펩티드, 면역용 펩티드의 제조 방법, 그것을 포함하는 면역 질환용 의약 조성물, 및 면역 질환의 치료 방법
AU2020295989A1 (en) * 2019-06-18 2022-01-20 The Scripps Research Institute Methods and compositions for treating inflammatory conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012737A2 (fr) * 1994-10-25 1996-05-02 Immulogic Pharmaceutical Corporation Compositions et traitement pour la sclerose en plaques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734023A (en) * 1991-11-19 1998-03-31 Anergen Inc. MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
KR19990022641A (ko) * 1995-06-07 1999-03-25 길버트 알. 민쯔 융합된 가용성 ｍｈｃ 헤테로이합체:펩티드 복합체 및 그것의 이용

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012737A2 (fr) * 1994-10-25 1996-05-02 Immulogic Pharmaceutical Corporation Compositions et traitement pour la sclerose en plaques

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9957241A3 *
WUCHERPFENNIG K W ET AL: "STRUCTURAL REQUIREMENTS FOR BINDING OF AN IMMUNODOMINANT MYELIN BASIC PROTEIN PEPTIDE TO DR2 ISOTYPES AND FOR ITS RECOGNITION BY HUMAN T CELL CLONES", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 179, no. 1, January 1994 (1994-01-01), pages 279 - 290, XP000655184, ISSN: 0022-1007 *

Also Published As

Publication number Publication date
NZ507901A (en) 2003-06-30
ZA200006268B (en) 2001-08-22
WO1999057241A9 (fr) 2000-02-17
HK1039636A1 (zh) 2002-05-03
AU3789099A (en) 1999-11-23
CA2330826A1 (fr) 1999-11-11
EP1080185A2 (fr) 2001-03-07
WO1999057241A3 (fr) 2000-01-13
JP2002513558A (ja) 2002-05-14
NO20005547L (no) 2001-01-02
NO20005547D0 (no) 2000-11-03
CN1308671A (zh) 2001-08-15
WO1999057241A2 (fr) 1999-11-11

Similar Documents

Publication Publication Date Title
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
PL346346A1 (en) Cyclic prosaposin-derived peptides and uses thereof
EP1064022A4 (fr) Peptides de liaison de hla et leurs applications
HUP0200414A2 (en) Interferon-betha fusion proteins and uses
GB9806806D0 (en) Peptides and uses thereof
EP1056465A4 (fr) Peptides antimicrobiens et metapeptides derives
AU5340399A (en) Proteases and associated proteins
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
AP2001002189A0 (en) Genes and proteins and their uses
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
EP1140976A4 (fr) Proteines secretees et leurs utilisations
EP0989136A4 (fr) Peptides a structures cycliques et a effet restaurateur d'activite de la proteine p53 sur les mutants de ladite proteine
EP1018551A4 (fr) Proteine megsine
IL128570A0 (en) Protein kinases and uses thereof
GB9918155D0 (en) Proteins and peptides
HK1039636A1 (zh) 髓磷脂碱性蛋白肽及其應用
GB9714276D0 (en) Peptides and related compounds
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
GB9700154D0 (en) Peptides
GB9720784D0 (en) Protein
EP0996457A4 (fr) Peptides liberateurs de f.s.h.
GB9824357D0 (en) Protein and DNA coding therefor
EP1142999A4 (fr) Proteine et adn associe
EP1111047A4 (fr) Nouvelle proteine et son adn

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001130

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20041215

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040602